Drug Search Results
More Filters [+]

Connective tissue growth factor

Alternative Names: connective tissue growth factor
Latest Update: 2024-05-14
Latest Update Note: PubMed Publication

Product Description

Mechanisms of Action: Protein Synthesis Modulator

Novel Mechanism: Yes

Modality: N/A

Route of Administration: N/A

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: FibroGen
Company Location: SAN FRANCISCO CA 94158
Company CEO: Enrique Conterno
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Connective tissue growth factor

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

Recent News Events